Effect of allogeneic Schwann cell transplantation on peripheral nerve regeneration.
Transplantation of allogeneic Schwann cells (SC) would make it feasible to reconstruct immediately peripheral nerve defects, compared to using autologous SC; however, this treatment modality has not been adequately evaluated. The aim of this study was to characterize and compare the effects of allogeneic versus syngeneic SC transplantation following peripheral nerve injury. Polyhydroxybutyrate conduits were used to bridge a 10-mm gap in the rat sciatic nerve. The conduits were filled with alginate hydrogel with or without cultured allogeneic or syngeneic genetically labeled SC, without the use of immunosuppressive therapy, and examined after 2, 3, and 6 weeks with 5-bromo-4-chloro-3-indoyl-beta-D-galactosidase chemical staining and immunohistochemistry to quantify SC migration into the conduit, axonal regeneration, the state of SC differentiation, and the expression of major histocompatibility complexes (MHC) I and II, as well as to quantify macrophage and B- and T-lymphocyte infiltration. Allogeneic SC were rejected by 6 weeks, whereas syngeneic SC could still be identified. Allogeneic and syngeneic SC equally enhanced the axonal regeneration distance but the quantity of axons was greater using syngeneic SC. The ingrowth of SC into the conduits containing allogeneic SC was similar to that observed in the presence of syngeneic SC, indicating the absence of deleterious immune response. SC continued to express phenotypic markers of nonmyelination and these were highest in conduits with allogeneic SC. Expression of MHC I and II was higher in the conduits with allogeneic SC at 3 weeks and without significant difference in the number of macrophages and lymphocytes, except at 6 weeks, when there was a larger number of lymphocytes using syngeneic SC. In conclusion, allogeneic SC enhanced axonal regeneration distance and did not induce a deleterious immune response. In a clinical setting the immediate availability of allogeneic SC for transplantation may compensate for the better outcome achieved by the use of autologous SC that require a longer preparation time in culture.
Mosahebi
Afshin
A
Blond McIndoe Centre, University Department of Surgery, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom.
Fuller
Paul
P
Wiberg
Mikael
M
Terenghi
Giorgio
G
D000464:Alginates; D000818:Animals; D001369:Axons; D002454:Cell Differentiation; D002465:Cell Movement; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology; D020007:Implants, Experimental; D009416:Nerve Regeneration / Q000276:immunology; D010525:Peripheral Nerves / Q000473:pathology* / Q000503:physiopathology / Q000601:surgery; D010641:Phenotype; D051381:Rats; D020318:Rats, Long-Evans; D012583:Schwann Cells / Q000637:transplantation*; D012584:Sciatic Nerve / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D020426:Sciatic Neuropathy / Q000628:therapy*; D023001:Transplantation Tolerance / Q000276:immunology; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D000464:Alginates